Company
neuvasq.com
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Neuvasq Biotechnologies is pioneering the development of first-in-class Gpr124- and Reck-targeting Wnt surrogate antibodies, designed to restore the integrity
Loading relationship preview